TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS (RAMEDA) S.A.E. Tenth Of Ramadan Pharmaceutical Industries & Diagnostic - Rameda (RMDA.CA) Reports Year Ended 31/12/2021 Consolidated Results
24/02/2022
24/02/2022
Company Name : Tenth Of Ramadan Pharmaceutical Industries & Diagnostic - Rameda
ISIN Code : EGS381B1C015
Currency : EGP
F/S Consolidated Period : From 01/01/2021 to 31/12/2021
Net Profit : 180,085,833
F/S Consolidated Period : From 01/01/2020 to 31/12/2020
Net Comparative Profit : 111,514,938
Audit Status : Audited
Source : Tenth Of Ramadan Pharmaceutical Industries & Diagnostic - Rameda
ISIN Code : EGS381B1C015
Currency : EGP
F/S Consolidated Period : From 01/01/2021 to 31/12/2021
Net Profit : 180,085,833
F/S Consolidated Period : From 01/01/2020 to 31/12/2020
Net Comparative Profit : 111,514,938
Audit Status : Audited
Source : Tenth Of Ramadan Pharmaceutical Industries & Diagnostic - Rameda
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Tenth of Ramadan for Pharmaceutical and Diagnostic Reagents Company SAE published this content on 24 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 February 2022 08:21:04 UTC.
